SE380529B - Analogiforfaranden for framstellning av nya azepinderivat - Google Patents

Analogiforfaranden for framstellning av nya azepinderivat

Info

Publication number
SE380529B
SE380529B SE7110347A SE1034771A SE380529B SE 380529 B SE380529 B SE 380529B SE 7110347 A SE7110347 A SE 7110347A SE 1034771 A SE1034771 A SE 1034771A SE 380529 B SE380529 B SE 380529B
Authority
SE
Sweden
Prior art keywords
analogical
procedures
preparation
azepine derivatives
new azepine
Prior art date
Application number
SE7110347A
Other languages
English (en)
Swedish (sv)
Inventor
G Griss
M Kleemann
W Grell
H Ballhause
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2040510A external-priority patent/DE2040510C3/de
Priority claimed from DE19712127267 external-priority patent/DE2127267A1/de
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of SE380529B publication Critical patent/SE380529B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7110347A 1970-08-14 1971-08-13 Analogiforfaranden for framstellning av nya azepinderivat SE380529B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2040510A DE2040510C3 (de) 1970-08-14 1970-08-14 Oxazole- und Thiazole eckige Klammer auf 5,4-d] azepin- Derivate
DE19712127267 DE2127267A1 (en) 1971-06-02 1971-06-02 2-amino-4,5,7,8-tetrahydro-6h-thiazolo-or oxazolo(5,4-d) - azepines - as hypotensive, antiphlogistic, sedative and bechic agents

Publications (1)

Publication Number Publication Date
SE380529B true SE380529B (sv) 1975-11-10

Family

ID=25759588

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7110347A SE380529B (sv) 1970-08-14 1971-08-13 Analogiforfaranden for framstellning av nya azepinderivat

Country Status (23)

Country Link
US (1) US3804849A (no)
JP (1) JPS5246236B1 (no)
AT (1) AT310174B (no)
AU (1) AU462319B2 (no)
BE (1) BE771330A (no)
BG (3) BG17786A3 (no)
CA (1) CA965423A (no)
CH (1) CH571003A5 (no)
CS (1) CS178084B2 (no)
DK (1) DK136654C (no)
ES (3) ES393881A1 (no)
FI (1) FI54925C (no)
FR (1) FR2102192B1 (no)
GB (1) GB1321509A (no)
HU (1) HU162343B (no)
IE (1) IE35517B1 (no)
IL (1) IL37492A (no)
NL (1) NL168516C (no)
NO (1) NO131887C (no)
PL (1) PL85080B1 (no)
RO (4) RO59127A (no)
SE (1) SE380529B (no)
YU (5) YU35027B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3907996A (en) * 1970-08-14 1975-09-23 Boehringer Sohn Ingelheim Pharmaceutical composition containing a 2-amino-4,5,7,8-tetrahydro-6H-thiazolo or -oxazolo 5,4-D azepine and method of use
BE795257A (fr) * 1972-02-10 1973-08-09 Thomae Gmbh Dr K Nouveaux oxazols
DE2820808A1 (de) * 1978-05-12 1979-11-22 Thomae Gmbh Dr K Arzneimittel mit einer antanginoesen wirksamkeit
US4400378A (en) * 1981-11-02 1983-08-23 Karl Thomae Gesellschaft Mit Beschrankter Haftung Pharmaceutical composition for the treatment of glaucoma
DE3680929D1 (de) 1985-02-06 1991-09-26 Boehringer Ingelheim Kg Verwendung des 2-amino-6-allyl-5,6,7,8-tetrahydro-4h-thiazolo(4,5-d)azepins zur herstellung eines zur behandlung der parkinsonschen erkrankung bzw. des parkinsonismus geeigneten arzneimittels.
US4826686A (en) * 1985-12-14 1989-05-02 Boehringer Ingelheim Kg Therapeutic system
DE3820775A1 (de) * 1988-06-20 1989-12-21 Thomae Gmbh Dr K Neue 4,5,7,8-tetrahydro-6h-thiazolo(5,4,-d)azepine, ihre herstellung und ihre verwendung als arzneimittel
JP3054738B2 (ja) * 1988-07-22 2000-06-19 武田薬品工業株式会社 チアゾロ［５，４―ｂ］アゼピン誘導体
US5424431A (en) * 1990-10-24 1995-06-13 Yamanouchi Pharmaceutical Co., Ltd. Thiazole derivatives
US6369222B1 (en) * 2000-07-18 2002-04-09 Hoffmann-La Roche Inc. mGluR antagonists and a method for their synthesis
PT1960346E (pt) * 2005-12-08 2011-05-23 Huntsman Int Llc Processo para preparar diaminodifenilmetanos
WO2009082268A2 (ru) 2007-12-21 2009-07-02 Alla Chem, Llc ЛИГАНДЫ α-АДРЕНОЦЕПТОРОВ, ДОПАМИНОВЫХ, ГИСТАМИНОВЫХ, ИМИДАЗОЛИНОВЫХ И СЕРОТОНИНОВЫХ РЕЦЕПТОРОВ И ИХ ПРИМЕНЕНИЕ
RU2374245C1 (ru) 2008-08-22 2009-11-27 Андрей Александрович Иващенко Лиганд с широким спектром одновременной рецепторной активности, фармацевтическая композиция, способ ее получения и лекарственное средство
US20110230472A1 (en) * 2008-08-29 2011-09-22 Shionogi & Co., Ltd. Ring-fused azole derivative having pi3k-inhibiting activity
TWI537274B (zh) 2011-03-14 2016-06-11 橘生藥品工業股份有限公司 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途
US9585885B2 (en) 2012-12-10 2017-03-07 Kissei Pharmaceutical Co., Ltd. Substituted pyrido[2,3-g]quinazolines as dopamine D2 receptor agonists
CN104031072A (zh) * 2014-06-24 2014-09-10 重庆植恩药业有限公司 一种盐酸他利克索的制备方法

Also Published As

Publication number Publication date
JPS5246236B1 (no) 1977-11-22
IE35517L (en) 1972-02-14
IE35517B1 (en) 1976-03-03
YU42168B (en) 1988-06-30
AU462319B2 (en) 1975-06-19
BG17785A3 (no) 1973-12-25
YU208471A (en) 1979-12-31
CH571003A5 (no) 1975-12-31
NO131887C (no) 1975-08-20
IL37492A (en) 1974-03-14
YU288178A (en) 1979-12-31
YU35028B (en) 1980-06-30
YU35027B (en) 1980-06-30
DK136654B (da) 1977-11-07
HU162343B (no) 1973-01-29
AU3241171A (en) 1973-02-22
BG17968A3 (no) 1974-03-05
RO59129A (no) 1976-01-15
FR2102192A1 (no) 1972-04-07
US3804849A (en) 1974-04-16
BE771330A (no) 1972-02-14
YU288378A (en) 1979-12-31
AT310174B (de) 1973-09-25
RO60635A (no) 1976-10-15
CS178084B2 (no) 1977-08-31
YU288478A (en) 1982-06-30
PL85080B1 (no) 1976-04-30
DK136654C (da) 1978-04-10
FI54925C (fi) 1979-04-10
YU288278A (en) 1982-06-30
RO59925A (no) 1976-08-15
CA965423A (en) 1975-04-01
FI54925B (fi) 1978-12-29
YU40542B (en) 1986-02-28
GB1321509A (en) 1973-06-27
NL7111176A (no) 1972-02-16
NO131887B (no) 1975-05-12
IL37492A0 (en) 1971-11-29
ES393881A1 (es) 1973-09-16
FR2102192B1 (no) 1974-11-15
ES396454A1 (es) 1974-05-16
NL168516C (nl) 1982-04-16
RO59127A (no) 1976-02-15
YU35029B (en) 1980-06-30
BG17786A3 (no) 1973-12-25
NL168516B (nl) 1981-11-16
ES396453A1 (es) 1974-05-16

Similar Documents

Publication Publication Date Title
SE393381B (sv) Analogiforfarande for framstellning av 8-azapurin - 6 - onderivat
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE394678B (sv) Analogiforfarande for framstellning av pyridokinolinderivat
SE390304B (sv) Analogiforfarande for framstellning av 4-hydroxi-5-etyl-6-fonylpyrimidin
SE380529B (sv) Analogiforfaranden for framstellning av nya azepinderivat
SE386445B (sv) Forfaranden for framstellning av nya bensotiadiazoler
SE406197B (sv) Analogiforfarande for framstellning av 4-aminokinazolinderivat
SE399701B (sv) Forfarande for framstellning av hydroxyalkyldiamin
SE394436B (sv) Forfarande for framstellning av 7-halogen-linkomyciner
SE380273B (sv) Forfarande for framstellning av tiopyrimidinderivat
SE392615B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE399069B (sv) Analogiforfarande for framstellning av triazolo-pyridino-isokinolin-derivat
SE382980B (sv) Forfarande for framstellning av nya derivat av hexahydrofenantridin
SE404801B (sv) Forfaranden for framstellning av nya tiazolderivat
SE385011B (sv) Forfarande for framstellning av alfa-linkosaminider
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE388611B (sv) Analogiforfarande for framstellning av 1,4-bensodiazeponderivat
SE408418B (sv) Forfarande for framstellning av 5-fluor-pyrimidiner
SE395699B (sv) Forfarande for framstellning av kinuklidin-kinolinderivat
SE408177B (sv) Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
SE386681B (sv) Forfarande for framstellning av nya cefalosporinderivat
SE384210B (sv) Forfarande for framstellning av nya nitrosokarbamidderivat
SE403112B (sv) Analogiforfarande for framstellning av skopolaminderivat
SE380795B (sv) Forfarande for framstellning av tiokarbamider
NO136409C (no) Fremgangsm}te for fremstilling av aryloksyalkyl-morfolinderivater